In addition to addressing the benefit and compensation provisions of the Coronavirus Aid Relief and Economic Security Act (the “CARES Act”) for their general employee population, most company boards of directors (or applicable board committees) are also grappling with the unique issues relating to compensation and benefits of their executive employees at an uncertain time when such employees are critical to the company’s ability to weather the storm. See our blog post on Mayer Brown’s COVID-19 blog (republished by the Harvard Law School Forum on Corporate Governance here) for a summary of some of the key executive compensation issues that boards and executives may want to consider during these trying times.